Latest On Vitro, S.A.B. de C.V (VITOF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-11-23 05:08 EST | Dividend | A dividend of $0.02 has been announced on Nov 15, 2022. It will be paid Nov 25, 2022 with an ex-dividend date of Nov 23, 2022. | Neutral |  |
| 2021-04-27 06:11 EST | Dividend | A dividend of $0.04 has been announced on Apr 21, 2021. It will be paid Apr 29, 2021 with an ex-dividend date of Apr 27, 2021. | Neutral | |
| 2021-03-06 05:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-04 18:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 19:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 02:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 20:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 11:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 03:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 23:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 06:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 18:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 03:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 06:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 07:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 19:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 15:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 10:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 02:57 EST | Financials | Company financials have been released. | Neutral | |
About Vitro, S.A.B. de C.V (VITOF):
Vitro, S. A. B. de C. V., through its subsidiaries, designs, manufactures, processes, distributes, and markets a range of glass products worldwide. It operates in two segments, Flat Glass and Glass Containers. The Flat Glass segment provides flat glass products for the construction and automotive industries. It also offers sodium carbonate, sodium bicarbonate, sodium chloride, and calcium chloride for use in glassmaking, detergents, water treatment, pharmaceuticals, food, oil, road de-icing, agriculture, and other applications. The Glass Containers segment provides glass containers for the cosmetics, perfumes and toiletries, and pharmaceuticals markets; and molds, as well as machineries and equipment for the glass container industry. It also offers engineering, equipment, and automation services for various industries. Vitro, S. A. B. de C. V. was founded in 1909 and is headquartered in San Pedro Garza GarcÃa, Mexico.
General
- Name Vitro, S.A.B. de C.V
- Symbol VITOF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorBasic Materials
- IndustrySpecialty Chemicals
- Full Time Employees 14,588
- Fiscal Year EndDecember
- Web URLhttp://www.vitro.com
View More
Valuation
- Trailing PE 13.11
- Price/Sales (Trailing 12 Mt.) 0.29
- Price/Book (Most Recent Quarter) 0.48
- Enterprise Value Revenue 0.25
- Enterprise Value EBITDA 2.35
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -3%
- Operating Margin 4%
- Return on Assets 2%
- Return on Equity -3%
- Revenue 1.77 billion
- Earnings Per Share $0.10
- Revenue Per Share $3.51
- Gross Profit 366.71 million
- Quarterly Earnings Growth -2.4%
View More
Highlights
- Market Capitalization 640.09 million
- EBITDA 222.15 million
- Book Value Per Share $2.75
View More
Share Statistics
- Shares Outstanding 474.14 million
- Shares Float 168.6 million
- % Held by Insiders <1%
- % Held by Institutions 2.31%
View More
Technicals
- Beta 0.52
- 52 Week High $1.45
- 52 Week Low $1
- 50 Day Moving Average 1.28
- 200 Day Moving Average 1.21
View More
Dividends
- Payout Ratio 44%
- Dividend Date 2005-04-06
- ExDividend Date 2019-02-26
- Dividend Per Share $0.1
- Dividend Yield 0%
View More
Vitro, S.A.B. de C.V (VITOF) Dividend Calendar:
VITOF's last dividend payment was made to shareholders on April 6, 2005.
Vitro, S.A.B. de C.V pays out 44% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Vitro, S.A.B. de C.V (VITOF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | -$0.28 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $0.03 | ||
| 2020-03-31 | 2020-06-30 | $500 million | -$0.13 | ||
| 2019-12-31 | 2020-03-31 | $504.87 million | $0.28 | ||
| 2019-09-30 | 2019-12-31 | $554 million | -$0.08 | ||
| 2019-06-30 | 2019-09-30 | $566 million | $0.08 | ||
| 2019-03-31 | 2019-06-30 | $555 million | $0.08 | ||
| 2018-12-31 | 2019-03-31 | $540.4 million | $0.05 | ||
| 2018-09-30 | 2018-12-31 | $573.22 million | $0.06 | ||
| 2018-06-30 | 2018-09-30 | $154.82 million | $0.12 | ||
| 2018-03-31 | 2018-06-30 | $557.65 million | $0.02 | ||
| 2017-12-31 | 2018-03-31 | $8.03 billion | $0.14 | ||
| 2017-09-30 | 2017-12-31 | $444.84 million | $0.09 | ||
| 2017-06-30 | 2017-09-30 | $10.41 billion | $0.12 | ||
| 2017-03-31 | 2017-06-30 | $8.49 billion | $0.09 | ||
| 2016-12-31 | 2017-03-31 | $7.45 billion | $0.09 | ||
| 2016-09-30 | 2016-12-31 | $0.11 | |||
| 2016-06-30 | 2016-09-30 | $0.11 | |||
| 2016-03-31 | 2016-06-30 | $0.09 | |||
| 2015-12-31 | 2016-03-31 | $0.09 | |||
| 2015-09-30 | 2015-12-31 | $0.03 | $0.49 | -93.98% | |
| 2015-06-30 | 2015-09-30 | -$0.14 | $0.44 | -132.91% | |
| 2015-03-31 | 2015-06-30 | $0.01 | |||
| 2014-12-31 | 2015-03-31 | -$0.04 | |||
| 2014-09-30 | 2014-10-28 | $-0.00 | |||
| 2014-06-30 | 2014-09-30 | -$0.07 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.02 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | -$0.03 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | -$0.04 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.07 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | -$0.05 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.12 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.10 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | -$0.05 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $1.31 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.03 | $0.00 |
Vitro, S.A.B. de C.V (VITOF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | 139 million | -51.34 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 93.35 million |
| Gross Profit | N/A | N/A | N/A | 115 million | 108 million |
| Ebit | N/A | N/A | N/A | 148 million | -524000 |
| Operating Income | N/A | N/A | N/A | 60 million | -524000 |
| Income Tax Expense | 52 million | 13 million | -21.92 million | N/A | -14.56 million |
| Total Revenue | N/A | N/A | N/A | 500 million | 504.87 million |
| Cost of Revenue | N/A | N/A | N/A | 385 million | 396.87 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -50.81 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | 132 million | -36.78 million |
| Net Income Applicable to Common Shares | -131 million | 14 million | -60.42 million | N/A | -36.83 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -19.85 million | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | -35.04 million | N/A | 9.59 million | -5.85 million |
| Total Cash Flow from Investing Activities | N/A | -17.74 million | N/A | -55.33 million | -41.97 million |
| Net Borrowings | N/A | 52.47 million | N/A | -4.45 million | -5.37 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -15.81 million | -21.74 million |
| Change to Operating Activities | N/A | 15.12 million | N/A | 10.64 million | -12.49 million |
| Change in Cash | N/A | N/A | N/A | 104.69 million | 4.24 million |
| Total Cash from Operating Activities | 70.57 million | -16.77 million | N/A | 172.91 million | 70.62 million |
| Depreciation | 36.26 million | N/A | N/A | 30.1 million | 39.16 million |
| Other Cash Flow from Investing Activities | N/A | 675000 | N/A | -3.02 million | -2.15 million |
| Change to Inventory | 16.83 million | N/A | N/A | -288000 | -7.69 million |
| Change to Account Receivables | N/A | N/A | N/A | 117.29 million | 764000 |
| Other Cash Flow from Financing Activities | N/A | -9.98 million | N/A | -11.33 million | -12.03 million |
| Change to Net Income | N/A | -26.04 million | N/A | 42.4 million | 16.13 million |
| Capital Expenditures | 20.8 million | N/A | N/A | 51.43 million | 38.36 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | 1.26 billion | 1.36 billion |
| Total Stockholder Equity | N/A | N/A | N/A | 1.37 billion | 1.43 billion |
| Other Current Liabilities | 158 million | 255 million | N/A | N/A | 164.93 million |
| Total Assets | N/A | N/A | N/A | 2.63 billion | 2.79 billion |
| Common Stock | 1.3 billion | 1.32 billion | 378.86 million | N/A | 378.86 million |
| Other Current Assets | 86 million | 66 million | N/A | 82 million | 2.53 million |
| Retained Earnings | N/A | N/A | 770.25 million | N/A | 698.15 million |
| Other Liabilities | 266 million | 867 million | 800.12 million | N/A | 245.11 million |
| Other Assets | 220 million | 255 million | 158 million | N/A | 174.08 million |
| Cash | N/A | N/A | N/A | 183 million | 230.17 million |
| Total Current Liabilities | 707 million | 467 million | N/A | 395 million | 418.34 million |
| Other Stockholder Equity | N/A | N/A | -154.58 million | N/A | 35.72 million |
| Property, Plant & Equipment | 1.21 billion | 1.2 billion | 1.26 billion | N/A | 1.34 billion |
| Total Current Assets | 1.13 billion | 881 million | N/A | 875 million | 943.65 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 14.68 million |
| Net Tangible Assets | 985 million | 1.01 billion | 998.38 million | N/A | 1.11 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | 619 million | 659.16 million |
| Inventory | 386 million | 364 million | N/A | 406 million | 420.43 million |
| Accounts Payable | 241 million | 212 million | N/A | 245 million | 235.35 million |
Vitro, S.A.B. de C.V (VITOF) Chart:
Vitro, S.A.B. de C.V (VITOF) News:
Below you will find a list of latest news for Vitro, S.A.B. de C.V (VITOF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Vitro, S.A.B. de C.V (VITOF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Vitro, S.A.B. de C.V (VITOF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|